Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Novo Nordisk logo above the entrance to their offices in Copenhagen (Reuters) - Novo Nordisk said on Wednesday it ...

After she was diagnosed at age 48 with Type 1 diabetes, Stacey Silverman muddled through her days with high blood sugar, fatigue and splitting headaches. Taking a long-acting form of insulin called ...

Novo Nordisk maintains that patients have ample time to transition to other options. Novo Nordisk, Eli Lilly, and Sanofi control 100% of the insulin market in the U.S Get two weeks of free access to ...

Levemir, one of the three types of long-acting basal insulins, is evacuating the U.S. market, and diabetes patient advocates told USA Today they’re worried about using a new medication after nearly ...

Insulin is an essential medicine that helps the body turn food into energy and regulate blood sugar levels for millions of people with diabetes nationwide. That makes access to insulin vital for ...

(Reuters) - Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available ...